Hirokazu Tanaka

2.5k total citations
110 papers, 1.8k citations indexed

About

Hirokazu Tanaka is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Hirokazu Tanaka has authored 110 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 20 papers in Molecular Biology and 18 papers in Immunology. Recurrent topics in Hirokazu Tanaka's work include Acute Myeloid Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immune Cell Function and Interaction (9 papers). Hirokazu Tanaka is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immune Cell Function and Interaction (9 papers). Hirokazu Tanaka collaborates with scholars based in Japan, Germany and United States. Hirokazu Tanaka's co-authors include Itaru Matsumura, Yuzuru Kanakura, Sachiko Ezoe, Yusuke Satoh, Hirohiko Shibayama, Ichiro Taniuchi, Yoshinori Naoe, J. Luis Espinoza, Taku Naito and Richard G. Pestell and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Hirokazu Tanaka

100 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirokazu Tanaka Japan 23 741 343 292 262 214 110 1.8k
Nikki Feirt United States 17 726 1.0× 263 0.8× 107 0.4× 381 1.5× 407 1.9× 20 2.1k
Isao Shirato Japan 29 833 1.1× 454 1.3× 175 0.6× 152 0.6× 231 1.1× 101 2.8k
Eeva‐Riitta Savolainen Finland 30 892 1.2× 250 0.7× 373 1.3× 262 1.0× 340 1.6× 109 2.8k
Hua Jiang China 27 1.4k 1.8× 460 1.3× 273 0.9× 620 2.4× 151 0.7× 125 2.5k
Tsukasa Matsubara Japan 30 618 0.8× 583 1.7× 472 1.6× 253 1.0× 420 2.0× 105 2.8k
Zhou Zhao China 19 683 0.9× 179 0.5× 160 0.5× 327 1.2× 153 0.7× 55 1.9k
Ningzheng Dong China 23 390 0.5× 385 1.1× 271 0.9× 156 0.6× 110 0.5× 98 1.6k
Yanming Zhang United States 23 932 1.3× 179 0.5× 494 1.7× 571 2.2× 124 0.6× 148 2.0k
Seung‐Hyun Jung South Korea 30 1.1k 1.5× 231 0.7× 139 0.5× 454 1.7× 407 1.9× 153 2.8k
J.M. Foidart Belgium 16 736 1.0× 247 0.7× 269 0.9× 583 2.2× 98 0.5× 49 2.1k

Countries citing papers authored by Hirokazu Tanaka

Since Specialization
Citations

This map shows the geographic impact of Hirokazu Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Tanaka more than expected).

Fields of papers citing papers by Hirokazu Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokazu Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Tanaka. The network helps show where Hirokazu Tanaka may publish in the future.

Co-authorship network of co-authors of Hirokazu Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Tanaka. A scholar is included among the top collaborators of Hirokazu Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Tanaka. Hirokazu Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Hirokazu, Ryosuke Fujiwara, Yasuyoshi Morita, et al.. (2025). Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells. Current Issues in Molecular Biology. 47(10). 797–797.
2.
Taniguchi, Takahide, Shoko Nakayama, Hirokazu Tanaka, et al.. (2022). Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL‐6 production in lymphoma cells. British Journal of Haematology. 198(2). 360–372. 2 indexed citations
3.
Tanaka, Hirokazu, Shinya Rai, Yasuhiro Taniguchi, et al.. (2022). C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis. International Journal of Hematology. 115(3). 310–321. 1 indexed citations
4.
Tanaka, Hirokazu, Takeshi Ueda, Takahide Taniguchi, et al.. (2022). CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence. International Journal of Hematology. 115(3). 336–349. 3 indexed citations
5.
Kitamura, Miho, S. Souma, Daisuke Wakabayashi, et al.. (2022). Development of a versatile micro-focused angle-resolved photoemission spectroscopy system with Kirkpatrick–Baez mirror optics. Review of Scientific Instruments. 93(3). 33906–33906. 1 indexed citations
6.
Fujiwara, Ryosuke, Yasuhiro Taniguchi, Shinya Rai, et al.. (2022). Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells. Biochemical and Biophysical Research Communications. 626. 156–166. 10 indexed citations
7.
Rai, Shinya, Hiroaki Inoue, Kazuko Sakai, et al.. (2021). Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma. Cancer Science. 113(2). 660–673. 11 indexed citations
8.
Rai, Shinya, Hirokazu Tanaka, Mai Suzuki, et al.. (2020). Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V. Nature Communications. 11(1). 4147–4147. 20 indexed citations
9.
Inoue, Hiroaki, Shinya Rai, Hirokazu Tanaka, et al.. (2020). Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy. Viruses. 12(4). 416–416. 2 indexed citations
10.
Inoue, Hiroaki, Shinya Rai, Hirokazu Tanaka, et al.. (2020). Tumour‐immune microenvironment in duodenal‐type follicular lymphoma. British Journal of Haematology. 191(2). 243–252. 8 indexed citations
11.
Kakinuma, Toshiyuki, Kaoru Kakinuma, Hirokazu Tanaka, & Michitaka Ohwada. (2020). Considerations for performing microwave endometrial ablation (MEA) – Three cases with abnormal test results of endometrial tissue discovered by chance when performing MEA. International Journal of Hyperthermia. 37(1). 749–752. 3 indexed citations
12.
Tanaka, Hirokazu, J. Luis Espinoza, Ryosuke Fujiwara, et al.. (2019). Excessive Reactive Iron Impairs Hematopoiesis by Affecting Both Immature Hematopoietic Cells and Stromal Cells. Cells. 8(3). 226–226. 29 indexed citations
13.
Rai, Shinya, Hirokazu Tanaka, Hiroaki Inoue, et al.. (2018). Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab. Cancers. 10(9). 304–304. 1 indexed citations
14.
Inoue, Hiroaki, Yasuyoshi Morita, Shinya Rai, et al.. (2017). Azacitidine therapy for low-risk myelodysplastic syndrome developing after solid organ transplantation.. PubMed. 58(2). 138–142.
15.
Hirao, Hirofumi, Yoichiro Uchida, Kentaro Kadono, et al.. (2015). The protective function of galectin‐9 in liver ischemia and reperfusion injury in mice. Liver Transplantation. 21(7). 969–981. 21 indexed citations
16.
Naito, Taku, Hirokazu Tanaka, Yoshinori Naoe, & Ichiro Taniuchi. (2011). Transcriptional control of T-cell development. International Immunology. 23(11). 661–668. 127 indexed citations
17.
Tanaka, Hirokazu, Taishiro Chikamori, Nobuhiro Tanaka, et al.. (2010). A flow-limiting stenosis is the major determinant of exercise-induced myocardial stunning in patients with coronary artery disease. Journal of Cardiology. 55(3). 337–344. 6 indexed citations
18.
Tanaka, Hirokazu, et al.. (2003). A Case of Advanced Thymic Carcinoma Completely Resected After Chemoradiotherapy. Haigan. 43(4). 335–340. 3 indexed citations
19.
Fujisawa, M., K Yamanaka, Hirokazu Tanaka, et al.. (2001). Expression of endothelial nitric oxide synthase in the Sertoli cells of men with infertility of various causes. British Journal of Urology. 87(1). 85–88. 35 indexed citations
20.
Fujisawa, Masato, Masanori Kanzaki, Hirokazu Tanaka, et al.. (1995). ALTERATION OF THE HYPOTHALAMUS‐PITUITARY‐TESTIS AXIS IN OLIGOZOOSPERMIC MEN WITH NORMAL GONADOTROPIN LEVELS. International Journal of Urology. 2(4). 273–276. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026